Delivery Order SPE2DB20D2104-SPE2DB25FNAMR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count) valued at $4,336.18. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 4, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $14,672.56 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). The contract is structured as a firm fixed price delivery order with a completion date of July 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitively awarded contract. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,141.02 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablet, unit dose, 30-count packages, with a ceiling value of $1,006.45. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 25, 2025. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $7,859.79 delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in quantities of 30 units. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of November 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,162.68 delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count) on November 10, 2025, with completion targeted for November 12, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under the...
- The Defense Logistics Agency awarded a $6,839.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count). This non-competitive delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $4,574.72 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 13, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count bottles) with a ceiling value of $1,064.79. This is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and the work will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This...
- The Defense Logistics Agency awarded a $1,970.02 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to conclude on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAMRDelivery Order
The Defense Logistics Agency awarded a $7,922.61 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This firm fixed-price contract, classified as a non-set-aside award, represents a competitive procurement through the federal medical supply chain system. The ultimate completion date is set for September 16, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. As a child contract under this prime vehicle, the order fulfills the company's role as a comprehensive pharmaceutical distributor for federal military and veteran healthcare systems. AmerisourceBergen Drug Corp's established relationship with the Defense Logistics Agency reflects its capability to deliver diverse pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 9/15/25 |